APOLLOHOSP - IntraDay Trade Analysis with Live Signals
← Back to ListKey Parameters
⭐ IntraDay Trade Rating: 3.8
✅ Positive
The stock exhibits strong momentum with a rising RSI and MACD, indicating upward price pressure. Furthermore, the company reported healthy profits in the last quarter, and there's positive news regarding Reddy’s reappointment.
⚠️ Limitation
The PEG ratio of 7.12 suggests that the stock is overvalued relative to its earnings growth, presenting a significant risk. Additionally, the high P/E ratio combined with industry PE at 48.5 indicates potential for future price corrections.
📉 Company Negative News
Recent news highlights Apollo Hospitals seeking Reddy’s reappointment and the issuance of ₹7,500 million NCDs. However, the Manipal Health IPO oversubscription suggests competition in the healthcare sector.
📈 Company Positive News
None found
🏭 Industry
The hospital industry is generally considered defensive and resilient, driven by long-term demographic trends and increasing healthcare expenditure. However, it's susceptible to regulatory changes and economic downturns impacting elective procedures.
🧾 Conclusion
A buy opportunity exists at a price of 8750 ₹, utilizing the current momentum. An initial exit level for profit-taking would be 9000 ₹, while a stop-loss order at 8600 ₹ provides protection against potential downside movement. Overall, the stock appears promising based on its recent performance and positive news, but cautious monitoring is advised due to valuation concerns.